ProQuest Associates IV LLC
CIK 1431819 · last filed 2017-04-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
14
Lifetime Open-Market Net
-$252.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | 10%+ Owner | 6,777 | $2.14 | $14.5K | -$252.45M | 9 | 2017-04-03 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-04-16 | — | Sell (S) | −215,656 | -$6.09M | |
| 2015-04-02 | — | Sell (S) | −249,816 | -$6.59M | |
| 2015-03-18 | — | Sell (S) | −201,236 | -$5.25M | |
| 2014-02-20 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +14,412,363 | $15.00M | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.